NASDAQ:FWP - Forward Pharma A/S Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$1.05 0.00 (0.00 %)
(As of 01/20/2019 04:00 PM ET)
Previous Close$1.05
Today's Range$0.9750 - $1.07
52-Week Range$0.71 - $5.75
Volume1,799 shs
Average Volume15,630 shs
Market Capitalization$49.54 million
P/E RatioN/A
Dividend YieldN/A
Beta2.36
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FWP
CUSIPN/A
Phone45-3344-4242

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.25 billion
Cash Flow$21.00 per share
Book Value$1.90 per share

Profitability

Miscellaneous

Employees5
Market Cap$49.54 million
OptionableNot Optionable

Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) posted its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.

When is Forward Pharma A/S's next earnings date?

Forward Pharma A/S is scheduled to release their next quarterly earnings announcement on Monday, April 29th 2019. View Earnings Estimates for Forward Pharma A/S.

Has Forward Pharma A/S been receiving favorable news coverage?

News coverage about FWP stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Forward Pharma A/S earned a news impact score of -1.4 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term.

Who are some of Forward Pharma A/S's key competitors?

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the folowing people:
  • Mr. Florian Schonharting, Co-Founder & Chairman (Age 49)
  • Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 41)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 61)

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $1.05.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $49.54 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is http://www.forward-pharma.com.

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is Ostergade 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 45-3344-4242 or via email at [email protected]


MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  197 (Vote Outperform)
Underperform Votes:  132 (Vote Underperform)
Total Votes:  329
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel